03Dec/13

Heart-failure exacerbation by saxagliptin called 'real' – Clinical Endocrinology News Digital Network

Heart-failure exacerbation by saxagliptin called ‘real’
Clinical Endocrinology News Digital Network
DALLAS – The glycemia-lowering drug saxagliptin led to a “real” excess of hospitalizations for heart failure in a 16,000-patient trial designed to examine the drug’s cardiovascular safety, but given saxagliptin’s overall safety in the study the signal

and more »

03Dec/13

Heart-failure exacerbation by saxagliptin called 'real' – Family Practice News Digital Network

Heart-failure exacerbation by saxagliptin called ‘real’
Family Practice News Digital Network
DALLAS – The glycemia-lowering drug saxagliptin led to a “real” excess of hospitalizations for heart failure in a 16,000-patient trial designed to examine the drug’s cardiovascular safety, but given saxagliptin’s overall safety in the study the signal

and more »